prior authorization

Prior authorization and decision trees: Roots of my frustrationUrologist Henry Rosevear, MD, thinks it may be time to bring patients into the prior authorization process.
The payer time drain: dealing with prior authorizationsDespite recent moves to streamline the prior authorization process, physicians still struggle mightily as they jump through payers’ hoops.
Payers to pharma: Here’s what we’re missing in hep C drugsA Precision for Value survey highlights what can be done in order to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment.
Top 10 challenges facing physicians in 2017
Top 10 challenges facing physicians in 2017For the fourth consecutive year, Medical Economics reveals its list of obstacles physicians will face in the coming year and, more importantly, how to overcome them.
Integrating pharmacy benefit, medical benefit cuts costsHere’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.
12 strategies to improving prior authorizations
Tips for battling prior authorizationsHow approval hassles for ordering tests or prescribing drugs can get in the way of caring for patients.
Insurers make prescribing biologics difficultA new study suggests that insurance coverage of biologics for psoriasis is becoming more challenging. The need for prior authorization is increasing, as are the average time from prior authorization submission to coverage decisions and prior authorization denial rates.
Electronic prior authorization and payers: Lessons from BCBSTwo presenters at the AMCP 2016 conference examine a Blue Cross and Blue Shield of Michigan pilot project to leverage technology for its medical specialty drug management program. Here are the lessons learned.
Shaping specialty pharmacy’s future: 4 perspectivesAt AMCP, four stakeholders representing the specialty pharmacy perspective, manufacturer perspective, payer perspective, and PBM perspective shared their thoughts on the future of specialty pharmacy.